199 related articles for article (PubMed ID: 19179187)
1. Treatment for patients with unknown primary cancer and favorable prognostic factors.
Hainsworth JD; Fizazi K
Semin Oncol; 2009 Feb; 36(1):44-51. PubMed ID: 19179187
[TBL] [Abstract][Full Text] [Related]
2. [Unknown primary cancer].
Furue H
Gan To Kagaku Ryoho; 1998 Jan; 25(1):1-6. PubMed ID: 9464322
[TBL] [Abstract][Full Text] [Related]
3. [Metastatic carcinoma of unknown origin].
Fizazi K; Culine S
Bull Cancer; 1998 Jul; 85(7):609-17. PubMed ID: 9752267
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in unknown primary cancer.
Culine S
Semin Oncol; 2009 Feb; 36(1):60-4. PubMed ID: 19179189
[TBL] [Abstract][Full Text] [Related]
5. Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary tumor site.
Hainsworth JD; Greco FA
Semin Oncol; 1993 Jun; 20(3):279-86. PubMed ID: 8503024
[TBL] [Abstract][Full Text] [Related]
6. Metastatic adeno or undifferentiated carcinoma from an unknown primary site--natural history and guidelines for identification of treatable subsets.
Kirsten F; Chi CH; Leary JA; Ng AB; Hedley DW; Tattersall MH
Q J Med; 1987 Feb; 62(238):143-61. PubMed ID: 3659256
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma of unknown primary (CUP).
Pavlidis N; Fizazi K
Crit Rev Oncol Hematol; 2009 Mar; 69(3):271-8. PubMed ID: 18977667
[TBL] [Abstract][Full Text] [Related]
8. [Unknown primary tumour--diagnostic strategies and treatment].
Møller AK; Gundgaard MG; Petersen BL; Daugaard G
Ugeskr Laeger; 2008 Nov; 170(48):3946-9. PubMed ID: 19087733
[TBL] [Abstract][Full Text] [Related]
9. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
[TBL] [Abstract][Full Text] [Related]
10. Malignancies of undetermined primary origin.
Bitran JD; Ultmann JE
Dis Mon; 1992 Apr; 38(4):213-60. PubMed ID: 1547698
[TBL] [Abstract][Full Text] [Related]
11. Treatment for patients with unknown primary carcinoma and unfavorable prognostic factors.
Greco FA; Pavlidis N
Semin Oncol; 2009 Feb; 36(1):65-74. PubMed ID: 19179190
[TBL] [Abstract][Full Text] [Related]
12. Managing carcinomas of unknown primary site.
Hainsworth JD; Greco FA
Oncology (Williston Park); 1988 Jul; 2(7):43-9, 52-4. PubMed ID: 3275052
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
14. Treatment of patients with cancer of unknown primary site.
Hainsworth JD; Greco FA
Important Adv Oncol; 1991; ():173-90. PubMed ID: 1869276
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of metastatic neoplasms with unknown primary.
Bochtler T; Löffler H; Krämer A
Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
[TBL] [Abstract][Full Text] [Related]
16. Overview of patient management and future directions in unknown primary carcinoma.
Varadhachary GR; Greco FA
Semin Oncol; 2009 Feb; 36(1):75-80. PubMed ID: 19179191
[TBL] [Abstract][Full Text] [Related]
17. The role of L1-CAM immunohistochemial staining in the diagnosis of abdominal-pelvic cancer of uncertain primary site in women.
Ben-Arie A; Huszar M; Ben-Zvi N; Smirnov A; Altevogt P; Fogel M
Eur J Surg Oncol; 2008 Jul; 34(7):795-9. PubMed ID: 17845837
[TBL] [Abstract][Full Text] [Related]
18. [Carcinoma unknown primary-clinical practice].
Onozawa Y
Gan To Kagaku Ryoho; 2014 Jul; 41(7):799-803. PubMed ID: 25131862
[TBL] [Abstract][Full Text] [Related]
19. [CUP syndrome: are there advances?].
Moll R
Verh Dtsch Ges Pathol; 2005; 89():125-36. PubMed ID: 18035682
[TBL] [Abstract][Full Text] [Related]
20. Cancer of unknown primary (CUP).
Pavlidis N; Fizazi K
Crit Rev Oncol Hematol; 2005 Jun; 54(3):243-50. PubMed ID: 15890271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
